FOI2026/1986

1. Please can you indicate how you currently assure appropriate use of NHS Payment Scheme Annex A (High Cost) Drugs (HCD) for your patients receiving treatment via NHS provider trusts (Please put a tick or a cross by all that apply and provide additional text where indicated)
   1. Blueteq®
   2. Other database software (please specify product used)
   3. ICB employed staff imbedded into provider trust organisation providing patient-level assurance to ICB
   4. ICB funding to provider trusts for assurance activities e.g. clinical audit (please provide a summary of your assurance process)
   5. Assurance is through monitoring monthly spend against agreed HCD budget
   6. Other/none, (please specify mechanism used, if any)

2. If using a bought in software product for HCD commissioning, please state month and year of next renewal date
3. Within the next 12 months, are you planning a review and assessment of your current HCD commissioning assurance processes (and products) to appraise options for future HCD commissioning?

1. Blueteq®

Assurance is through monitoring monthly spend against agreed HCD budget

2. Blueteq – March 2028
3. No such plans.